Diagnosis and management of neurological sarcoidosis

Archives of Internal Medicine

Volumn 157, Issue 16, 1997, Pages 1864-1868

  Lower, Elyse E ^a   Broderick, Joseph P ^a   Brott, Thomas G ^a   Baughman, Robert P ^a,b  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; METHOTREXATE; PREDNISONE;

ARTICLE; CLINICAL FEATURE; DRUG EFFICACY; FACIAL NERVE PARALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; SARCOIDOSIS; STEROID THERAPY;

EID: 0030752586     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.157.16.1864     Document Type: Article

References (39)

1. Siltzbach LE, James DG, Neville E, et al. Course and prognosis of sarcoidosis around the world. Am J Med. 1974;57:847-852.
2. Delaney P. Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases. Ann Intern Med. 1977;87:336-345.
3. Maycock RL, Bertrand P, Morrison CE. Manifestations of sarcoidosis. Am J Med. 1963;35:67-89.
4. Stern BJ, Krumholz A, Johns C, Scott P, Nissim J. Sarcoidosis and its neurological manifestations. Arch Neurol. 1985;42:909-917.
5. Chen RC, McLeod JG. Neurological complications of sarcoidosis. Med J Aust. 1992;156:815.
6. Chapelon C, Ziza JM, Piette JC, et al. Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine (Baltimore). 1990;69:261-276.
7. Krumholz A, Stern BJ, Stern EG. Clinical implications of seizures in neurosarcoidosis. Arch Neurol. 1991;48:842-884.
8. Colover J. Sarcoidosis with involvement of the nervous system. Brain. 1948;71: 451-475.
9. Oksanen V. Neurosarcoidosis: clinical presentations and course in 50 patients. Acta Neurol Scand. 1986;73:283-290.
10. Agbogu BN, Stern BJ, Sewell C, Yang G. Therapeutic considerations in patients with refractory neurosarcoidosis. Arch Neurol. 1995;52:875-879.
11. Stern BJ, Schonfeld SA, Sewell C, Krumholz A, Scott P, Belendiuk G. The treatment of neurosarcoidosis with cyclosporine. Arch Neurol. 1992;49:1065-1072.
12. Lower EE, Baughman RP. Prolonged use of methotrexate for sarcoidosis. Arch Intern Med. 1995;155:846-851.
13. Zuber M, Defer G, Cesaro P, Degos JD. Efficacy of cyclophosphamide in sarcoid radiculomyelitis. J Neurol Neurosurg Psychiatry. 1992;55:166-167.
14. Demeter SL. Myocardial sarcoidosis unresponsive to steroids: treatment with cyclophosphamide. Chest. 1988;94:202-203.
15. Sharma OP. Neurosarcoidosis. Chest. 1991;100:301-302.
16. Kavanaugh AF, Andrew SL, Cooper B, Lawrence EC, Huston DP. Cyclosporine therapy of central nervous system sarcoidosis. Am J Med. 1987;82:387.
17. Ahmad K, Kim YH, Spitzer AR, et al. Total nodal radiation in progressive sarcoidosis: case report. Am J Clin Oncol. 1992;15:311-313.
18. Rubinstein I, Gray TA, Moldofsky H, Hoffstein V. Neurosarcoidosis associated with hypersomnolence treated with corticosteroids and brain irradiation. Chest. 1988;94:205-206.
19. Sharma OP, Badr A. Sarcoidosis: diagnosis, staging, and the role of newer diagnostic modalities. Clin Pulmonary Med. 1994;1:19-26.
20. Lexa FJ, Grossman RI. MR of sarcoidosis in the head and spine: spectrum of manifestations and radiographic response to steroid therapy. AJNR Am J Neuroradiol. 1994;15:973-982.
21. Gainsborough N, Hall SM, Hughes RA, Leibowitz S. Sarcoid neuropathy. J Neurol. 1991;238:177-180.
22. Lower EE, Baughman RP. The use of low dose methotrexate in refractory sarcoidosis. Am J Med Sci. 1990;299:153-157.
23. Baughman RP, Lower EE. Use of intermittent, intravenous cyclophosphamide for idiopathic pulmonary fibrosis. Chest. 1992;102:1090-1094.
24. O'Brien GM, Baughman RP, Broderick JP, Arnold L, Lower EE. Paranoid psychosis due to neurosarcoidosis. Sarcoidosis. 1994;11:34-36.
25. Oksann VE. Neurosarcoidosis. In: James DG, ed. Sarcoidosis and Other Granulomatous Disorders. New York, NY: Marcel Dekker Inc; 1994:285-309.
26. James DG, Sharma OP. Neurosarcoidosis. Proc R Soc Med. 1967;60:1169-1170.
27. Mayer SA, Yim GK, Onesti ST, Lynch T, Faust PL, Marder K. Biopsy-proven isolated sarcoid meningitis: case report. J Neurosurg. 1993;78:994-996.
28. Kadakia JK, Collette PM, Sharma OP. Role of magnetic resonance imaging in neurosarcoidosis. Sarcoidosis. 1993;10:98-99.
29. Miller DH, Kendall BE, Barter S, et al. Magnetic resonance imaging in central nervous system sarcoidosis. Neurology. 1988;38:378-383.
30. Akova YA, Kansu T, Duman S. Pseudotumor cerebri secondary to durai sinus thrombosis in neurosarcoidosis. J Clin Neuroophthalmol. 1993;13:188-189.
31. Oksanen V, Fyhrquist F, Gronhagen-Riska C, Somer H. CSF angiotensin-converting enzyme in neurosarcoidosis. Lancet. 1985;1:1050-1051.
32. Juozevicius JL, Rynes RI. Increased helper/suppressor T-lymphocyte ratio in the cerebrospinal fluid of a patient with neurosarcoidosis. Ann Intern Med. 1986; 104:807-808.
33. Stern BJ, Griffin DE, Luke RA, Krumholz A, Johns CJ. Neurosarcoidosis: cerebrospinal fluid lymphocyte subpopulations. Neurology. 1987;37:878-881.
34. Rebuck AS, Sanders BR, MacFadden DK, Man SF, York EL, Cohen RD. Cyclosporin in pulmonary sarcoidosis. Lancet. 1987;1:1486.
35. Martinet Y, Pinkston P, Saltini C, Spurzem J, Muller-Quernheim J, Crystal RG. Evaluation of the in vitro and in vivo effects of cyclosporine on the lung T-lymphocyte alveolitis of active pulmonary sarcoidosis. Am Rev Respir Dis. 1988; 138:1242-1248.
36. Casavilla FA, Gordon R, Wright HI, Gavaler JS, Starzl TE, van Thiel DH. Clinical course after liver transplantation in patients with sarcoidosis. Ann Intern Med. 1993;118:865-866.
37. Martinez FJ, Orens JB, Deeb M, Brunsting LA, Flint A, Lynch JP. Recurrence of sarcoidosis following bilateral allogeneic lung transplantation. Chest. 1994;106: 1597-1599.
38. Kazerooni EA, Jackson C, Cascade PN. Sarcoidosis: recurrence of primary disease in transplanted lungs. Radiology. 1994;192:461-464.
39. Stillwell TJ, Benson RC Jr. Cyclophosphamide-induced hemorrhagic cystitis: a review of 100 patients. Cancer. 1988;61:451-457.